EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia (Q38345216)

2 September 2017

EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia (English)

1 reference

2 September 2017

1 reference

1 reference

B V Balgobind

1

1 reference

2 September 2017

S Lugthart

2

1 reference

2 September 2017

I H Hollink

3

1 reference

2 September 2017

S T J C M Arentsen-Peters

4

1 reference

2 September 2017

E R van Wering

5

1 reference

2 September 2017

S S N de Graaf

6

1 reference

2 September 2017

D Reinhardt

7

1 reference

2 September 2017

U Creutzig

8

1 reference

2 September 2017

G J L Kaspers

9

1 reference

2 September 2017

E S J M de Bont

10

1 reference

2 September 2017

J Stary

11

1 reference

2 September 2017

J Trka

12

1 reference

2 September 2017

M Zimmermann

13

1 reference

2 September 2017

H B Beverloo

14

1 reference

2 September 2017

R Pieters

15

1 reference

2 September 2017

R Delwel

16

1 reference

2 September 2017

C M Zwaan

17

1 reference

2 September 2017

M M van den Heuvel-Eibrink

18

1 reference

2 September 2017

1 April 2010

1 reference

2 September 2017

1 reference

2 September 2017

24

1 reference

2 September 2017

942-949

1 reference

2 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.47

2 September 2017

0 references

cites work

The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

EVI1 and hematopoietic disorders: history and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5'-ends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

The roles of FLT3 in hematopoiesis and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Prognostically useful gene-expression profiles in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

7 January 2021

Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

7 January 2021

Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

7 January 2021

Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

7 January 2021

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

7 January 2021

Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

7 January 2021

Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.47

7 January 2021

Identifiers

DOI

10.1038/LEU.2010.47

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference